Kezar Life Sciences

Kezar Faces Significant Staff Loss, CEO Persists in Advancing Lead Lupus Candidate to Phase 2 Milestone

Kezar Faces Significant Staff Loss, CEO Persists in Advancing Lead Lupus Candidate to Phase 2 Milestone

Anika Sharma

Kezar Life Sciences is embarking on a significant restructuring plan aimed at preserving cash resources over the next two years ...

Inventiva Hepalys Pharma NASH deal, Kezar Everest Medicines lupus deal, Lanifibranor NASH Japan South Korea, Zetomipzomib lupus nephritis China, Inventiva Kezar Asian milestones and royalties, NASH and lupus nephritis treatments, Hepalys Pharma and Everest Medicines biotechs,

Inventiva and Kezar partner with Asian biotechs to advance NASH and lupus drugs

Anika Sharma

In a strategic move, Inventiva and Kezar Life Sciences have successfully secured buyers for the Asian rights to their lead ...